Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial

Reuters10-01

Oct 1 (Reuters) - Adagio Medical Holdings Inc ::
*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA
*ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 01-OCT-202512:00:02.96 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2572320115?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-01 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572320115","market":"us","top_or_hot":-1,"title":"Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial","media":"Reuters","content":"<html><body>Oct 1 (Reuters) - Adagio Medical Holdings Inc <adgm.o>::<br/>*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA<br/>*ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 01-OCT-202512:00:02.96 GMT</adgm.o></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-01 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Oct 1 (Reuters) - Adagio Medical Holdings Inc <adgm.o>::<br/>*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA<br/>*ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 01-OCT-202512:00:02.96 GMT</adgm.o></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nRSD8jRSgQ:1","article_id":"2572320115","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572320115","pubTimestamp":1759327458,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Oct 1 (Reuters) - Adagio Medical Holdings Inc ::*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRIC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","ADGM":"Adagio Medical Holdings, Inc."},"translate_title":"Adagio Medical完成VT冷冻消融关键试验的入组","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADGM":0.9},"content_text":"Oct 1 (Reuters) - Adagio Medical Holdings Inc ::*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA*ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 01-OCT-202512:00:02.96 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2572320115","isCrawlerRequest":true}